Answers are grounded in this paper and cite their sources.
Because of concern about the safety of immune globulins prepared for injection, we studied the effects of ethanol fractionation of human plasma on human lymphotropic virus, type III, (HTLV-III) by spiking the products of various fractionation steps with HTLV-III. Tests of inactivation and removal indicated that the ratio of residual live virus in plasma fractions/live virus in starting plasma was about 1 X 10(-15) for precipitate II from which immune globulin for injection is manufactured. The results are reassuring regarding the potential safety of immune globulin.
No takes yet. Share an insight, caveat, or question.
Wells et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: